How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

Cancer

Volumn 117, Issue 18, 2011, Pages 4166-4174

  Wilschut, Janneke A ^a   Steyerberg, Ewout W ^a   Van Leerdam, Monique E ^a   Lansdorp Vogelaar, Iris ^a   Habbema, J Dik F ^a   Van Ballegooijen, Marjolein ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

colonoscopy; colorectal neoplasm; cost effectiveness analysis; early detection of cancer; familial risk

Indexed keywords

ADENOMA DWELL TIME; ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TIME;

AGE FACTORS; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FAMILY HEALTH; HEALTH PLANNING GUIDELINES; HUMANS; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 80052502060     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26009     Document Type: Article

References (53)

1. Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol. 2006; 59: 114-124. (Pubitemid 43111615)
2. Butterworth AS, Higgins JP, Pharoah P,. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006; 42: 216-227. (Pubitemid 43083493)
3. Johns LE, Houlston RS,. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001; 96: 2992-3003. (Pubitemid 32959544)
4. de Jong AE, Vasen HF,. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med. 2006; 64: 367-370. (Pubitemid 44811213)
5. Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG,. Prevalence of family history of colorectal cancer in the general population. Br J Surg. 2005; 92: 1161-1164. (Pubitemid 41284883)
6. Jasperson KW, Tuohy TM, Neklason DW, Burt RW,. Hereditary and familial colon cancer. Gastroenterology. 2010; 138: 2044-2058.
7. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000; 118: 829-834. (Pubitemid 30243745)
8. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977-1981. (Pubitemid 24015040)
9. Brenner H, Hoffmeister M, Haug U,. Family history and age at initiation of colorectal cancer screening. Am J Gastroenterol. 2008; 103: 2326-2331.
10. Burt RW,. Colon cancer screening. Gastroenterology. 2000; 119: 837-853.
11. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
12. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008; 134: 1570-1595. (Pubitemid 351615355)
13. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A,. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000; 95: 868-877. (Pubitemid 30196719)
14. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003; 124: 544-560. (Pubitemid 36169269)
15. Loeve F, Boer R, Van Oortmarssen GJ, Van Ballegooijen M, Habbema JDF,. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res. 1999; 32: 13-33. (Pubitemid 29102594)
16. Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD,. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst. 2000; 92: 557-563. (Pubitemid 30212317)
17. Vogelaar I, van Ballegooijen M, Zauber AG, et al. Model Profiler of the MISCAN-Colon microsimulation model for colorectal cancer. Rotterdam, the Netherlands: Department of Public Health, Erasmus MC; 2004.
18. Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JD,. A novel hypothesis on the sensitivity of the fecal occult blood test: results of a joint analysis of 3 randomized controlled trials. Cancer. 2009; 115: 2410-2419.
19. Loeve F, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JDF, Final report MISCAN-COLON microsimulation model for colorectal cancer: report to the National Cancer Institute Project No. NO1-CN55186. Rotterdam, the Netherlands: Department of Public Health, Erasmus University; 1998.
20. Loeve F, Boer R, Zauber AG, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer. 2004; 111: 633-639. (Pubitemid 39045333)
21. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006; 107: 1624-1633. (Pubitemid 44546924)
22. Arminski TC, McLean DW,. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964; 7: 249-261.
23. Blatt L,. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 1961; 4: 277-282.
24. Bombi JA,. Polyps of the colon in Barcelona, Spain: an autopsy study. Cancer. 1988; 61: 1472-1476. (Pubitemid 18076428)
25. Chapman I,. Adenomatous polypi of large intestine: incidence and distribution. Ann Surg. 1963; 157: 223-226.
26. Clark JC, Collan Y, Eide TJ, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer. 1985; 36: 179-186. (Pubitemid 15243443)
27. Jass JR, Young PJ, Robinson EM,. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut. 1992; 33: 1508-1514.
28. Johannsen LG, Momsen O, Jacobsen NO,. Polyps of the large intestine in Aarhus, Denmark An autopsy study. Scand J Gastroenterol. 1989; 24: 799-806. (Pubitemid 19226933)
29. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM,. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979; 43: 1847-1857. (Pubitemid 9203736)
30. Vatn MH, Stalsberg H,. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982; 49: 819-825. (Pubitemid 12165443)
31. Williams AR, Balasooriya BA, Day DW,. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982; 23: 835-842. (Pubitemid 12018511)
32. Surveillance Research Program. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Software, version 5.3.1. Bethesda, MD: National Cancer Institute; 2003.
33. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130: 1872-1885. (Pubitemid 43668826)
34. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS,. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991; 37: 125-127.
35. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112: 24-28. (Pubitemid 27008981)
36. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS,. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997; 112: 17-23. (Pubitemid 27008980)
37. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006; 145: 880-886. (Pubitemid 351639963)
38. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G,. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000; 343: 162-168. (Pubitemid 30489212)
39. Pox C, Schmiegel W, Classen M,. Current status of screening colonoscopy in Europe and in the United States. Endoscopy. 2007; 39: 168-173. (Pubitemid 46394831)
40. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006; 355: 1863-1872. (Pubitemid 44664644)
41. Jentschura D, Raute M, Winter J, Henkel T, Kraus M, Manegold BC,. Complications in endoscopy of the lower gastrointestinal tract. Therapy and prognosis. Surg Endosc. 1994; 8: 672-676.
42. Zauber A, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen MM, Kuntz KM,. Cost-effectiveness of DNA stool testing to screen for colorectal cancer: report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. 2007. Available at: http://www.cms.gov/determinationprocess/downloads/id52TA.pdf.
43. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008; 100: 630-641.
44. Hunt TL, Luce BR, Page MJ, Pokrzywinski R,. Willingness to pay for cancer prevention. Pharmacoeconomics. 2009; 27: 299-312.
45. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375: 1624-1633.
46. Ness RM, Holmes AM, Klein R, Dittus R,. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol. 1999; 94: 1650-1657. (Pubitemid 29260460)
47. Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000; 88: 1294-1303. (Pubitemid 30155164)
48. Dove-Edwin I, de Jong AE, Adams J, et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology. 2006; 130: 1995-2000. (Pubitemid 43816950)
49. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ,. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005; 331: 1047.
50. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ,. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009; 101: 1412-1422.
51. Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M,. Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control. 2010; 21: 2287-2293.
52. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009; 27: 686-893.
53. Colorectal Cancer Risk Assessment Tool. Bethesda, MD: National Cancer Institute; 2008.